Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Products
Case Name (Date)
Yamasaki et al v. Zicam LLC and Matrixx Initiatives, Inc.
21-cv-2596, N.D. Cal.
(June 2021)
Product/Service
Zicam Original RapidMelts, Zicam ULTRA RapidMelts, Zicam Elderberry Citrus RapidMelts, Zicam Nasal Swabs, Zicam Nasal Spray, Zicam Wild Cherry Lozenges, and Zicam Oral Mist
Allegations
Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Status
Dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
Class-Action Tracker
Zicam Pre-Cold Remedies
Zicam Pre-Cold Medicine Products
The Latest
NJ tax dollars spent on ‘Blue Ribbon’ school awards that critics call deceptive
Julie O’Connor, Nj Spotlight News
The Regulatory Loopholes Behind Prevagen’s Rise
Sara Talpos, Med Shadow
CATrends: Tequilas Marketed as 100% Agave
Ingredient claims come into the limelight.
Jimmy Dean Breakfast Burritos
Beware of food images wrapped in deception.
The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.